KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Levi Strauss (LEVI) Asset Writedowns and Impairment (2016 - 2025)

Levi Strauss' Asset Writedowns and Impairment history spans 14 years, with the latest figure at $7.2 million for Q2 2025.

  • For Q2 2025, Asset Writedowns and Impairment changed N/A year-over-year to $7.2 million; the TTM value through Mar 2026 reached $7.2 million, down 93.97%, while the annual FY2025 figure was $2.5 million, 97.86% down from the prior year.
  • Asset Writedowns and Impairment reached $7.2 million in Q2 2025 per LEVI's latest filing, up from $2.5 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $111.4 million in Q3 2024 to a low of -$12.8 million in Q4 2021.
  • Average Asset Writedowns and Impairment over 5 years is $28.7 million, with a median of $7.4 million recorded in 2021.
  • The largest YoY upside for Asset Writedowns and Impairment was 4174.07% in 2021 against a maximum downside of 312.98% in 2021.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at -$12.8 million in 2021, then soared by 570.15% to $60.4 million in 2022, then skyrocketed by 49.34% to $90.2 million in 2023, then rose by 23.5% to $111.4 million in 2024, then crashed by 93.54% to $7.2 million in 2025.
  • Per Business Quant, the three most recent readings for LEVI's Asset Writedowns and Impairment are $7.2 million (Q2 2025), $2.5 million (Q1 2025), and $111.4 million (Q3 2024).